Literature DB >> 7991641

The importance of 5-hydroxytryptamine receptors in the gut.

N W Read1, K A Gwee.   

Abstract

Most of the 5-hydroxytryptamine (5-HT) present in the adult human body is located in the gastrointestinal tract. The vast majority is contained in enteroendocrine cells, the rest exists mainly in myenteric interneurons separated from the mucosa by an intraenteric barrier. Physiological studies suggest that 5-HT plays a vital role in mediating both sensory and reflex responses to gastrointestinal stimuli and, thus, this transmitter is closely implicated in gut reactions. This review outlines some of the evidence for different 5-HT receptors, summarizes the role of 5-HT in mediating gut sensitivity and motor activity, secretion and more complex activities, such as emesis and diarrhoea and identifies the clinical role of drugs acting on 5-HT receptors in the treatment of emesis, diarrhoea, the control of abdominal pain and discomfort and the rectification of gastrointestinal motility.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991641     DOI: 10.1016/0163-7258(94)90009-4

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  22 in total

Review 1.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

2.  5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine.

Authors:  Pawan Kumar Shahi; Seok Choi; Dong Chuan Zuo; Cheol Ho Yeum; Pyung Jin Yoon; Jun Lee; Young Dae Kim; Chan Guk Park; Man Yoo Kim; Hye Rang Shin; Hyun Jung Oh; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

3.  Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications.

Authors:  K Michel; H Sann; C Schaaf; M Schemann
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

4.  Paroxetine for somatic pain associated with physical illness: a review.

Authors:  Prakash S Masand; Meera Narasimhan; Ashwin A Patkar
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.

Authors:  Hirotada Akiho; Eikichi Ihara; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2010-08-15

Review 6.  Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.

Authors:  F De Ponti; M Tonini
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.

Authors:  Byung Gun Lim; Sang-Sik Choi; Yu Jin Jeong; Young Jin Lim; Yong Chul Kim; Kyoung Un Park; Dong Kyu Lee; Mi Kyoung Lee
Journal:  Korean J Anesthesiol       Date:  2014-12-29

8.  Increased 5-hydroxytryptamine mediates post-inflammatory visceral hypersensitivity via the 5-hydroxytryptamine 3 receptor in rats.

Authors:  Yun-Dong Choi; Tae-Sik Sung; Hyun-Ju Kim; Jun-Ho La; Tae-Wan Kim; Il-Suk Yang
Journal:  Dig Dis Sci       Date:  2008-03-21       Impact factor: 3.199

Review 9.  Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Authors:  Khaled A Jadallah; Susan M Kullab; David S Sanders
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Authors:  D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; J L McCullough; C Sandlund; C Richardson; N Mai; P P A Humphrey
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.